RHENMAN & PARTNERS ASSET MANAGEMENT AB – Iovance Biotherapeutics, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$4.76M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -3.77% | -20K shares | -1.08M | $9.58 | 510K |
Q2 2022 | share | Increase | +11.58% | 55K shares | -2.05M | $11.04 | 530K |
Q1 2022 | share | Decrease | -20.83% | -125K shares | -3.74M | $16.65 | 475K |
Q4 2021 | share | Increase | +87.50% | 280K shares | 3.76M | $19.42 | 600K |
Q3 2021 | share | Increase | +6.67% | 20K shares | 85K | $24.66 | 320K |
Q2 2021 | share | Increase | +1.69% | 5K shares | -1.53M | $26.02 | 300K |
Q1 2021 | share | Decrease | -7.81% | -25K shares | -5.50M | $31.66 | 295K |
Q4 2020 | share | Decrease | -5.88% | -20K shares | 3.65M | $46.4 | 320K |
Q3 2020 | share | 0.00% | 0 shares | 1.86M | $32.92 | 340K | |
Q2 2020 | share | Decrease | -6.85% | -25K shares | -1.59M | $27.45 | 340K |
Q1 2020 | share | Decrease | -23.16% | -110K shares | -2.22M | $29.94 | 365K |
Q4 2019 | share | Decrease | -8.65% | -45K shares | 3.68M | $27.68 | 475K |
Q3 2019 | share | Decrease | -30.73% | -230.7K shares | -8.94M | $18.2 | 520K |
Q2 2019 | share | Decrease | -14.65% | -128.9K shares | 10.04M | $24.52 | 750.7K |
Q1 2019 | share | Decrease | -27.03% | -325.89K shares | -2.30M | $9.51 | 879.6K |
Q4 2018 | share | Decrease | -6.59% | -85K shares | -3.84M | $8.85 | 1.20M |
Q3 2018 | share | Increase | +52.28% | 443.01K shares | 3.67M | $11.25 | 1.29M |
Q2 2018 | share | Decrease | -10.24% | -96.70K shares | -5.10M | $12.8 | 847.47K |
Q1 2018 | share | 0.00% | 0 shares | 8.40M | $16.9 | 944.18K | |
Q4 2017 | share | Increase | +32.77% | 233.02K shares | 2.04M | $8 | 944.18K |
Q3 2017 | share | Increase | +9.41% | 61.16K shares | 734K | $7.75 | 711.16K |
Q2 2017 | share | Increase | 0.00% | 650K shares | 4.77M | $7.35 | 650K |